Status:
COMPLETED
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Forest Laboratories
Conditions:
Frontotemporal Lobar Degeneration
Eligibility:
All Genders
40-80 years
Phase:
PHASE4
Brief Summary
This is a 52-week, multicenter, open label trial of memantine (Namenda) for frontotemporal lobar degeneration (FTLD). The goal is to determine the safety and tolerability of this FDA-approved medicati...
Eligibility Criteria
Inclusion
- Neary et al. Criteria for Frontotemporal Lobar Degeneration
- Age 40 -80
- CDR \< 3 or MMSE \> 15
- English Speaking
- Study Partner
Exclusion
- Concurrent use of antipsychotic drugs or acetylcholinesterase inhibitors
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00187525
Start Date
May 1 2004
End Date
October 1 2006
Last Update
November 12 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.